(Total Views: 697)
Posted On: 11/25/2020 12:09:31 PM
Post# of 154171
Sean,
The total patients receiving leronlimab to date is in the neighborhood of 1000, with a smaller subset, maybe a few hundred continuing to receive it post trial. Maybe 200?
With case positivity in US around 3%, only an expectation that 6 might get Covid.
Matching against a placebo/non-leronlimab group, it will be hard to make any determination in what is effectively and open label “trial” so few patients.
That’s my take on the situation.
The total patients receiving leronlimab to date is in the neighborhood of 1000, with a smaller subset, maybe a few hundred continuing to receive it post trial. Maybe 200?
With case positivity in US around 3%, only an expectation that 6 might get Covid.
Matching against a placebo/non-leronlimab group, it will be hard to make any determination in what is effectively and open label “trial” so few patients.
That’s my take on the situation.
(1)
(0)
